FDA
approval
· 2022-09-22
FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% — Original Application (NorthStar RxLLC)
Summary
The FDA approved NorthStar RxLLC's timolol maleate ophthalmic gel forming solution 0.25% under an Original Application (ANDA) for open-angle glaucoma and ocular…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25%)